MPS Earnings Call Transcript: Key Takeaways
MPS delivers record Q1 FY27 results, leveraging high operating leverage and AI integration to drive EBITDA growth significantly faster than revenue.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
MPS delivers record Q1 FY27 results, leveraging high operating leverage and AI integration to drive EBITDA growth significantly faster than revenue.
MPS reports record Q1 FY27 results with 20.38% revenue growth and 53.03% EBITDA surge, driven by the Unbound Medicine acquisition and AI-enabled workflows.
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.
MPS closed FY26 with record profitability, driven by its transformation into an AI-first knowledge solutions provider and the successful integration of Unbound Medicine.
MPS Limited reported record FY26 EPS of ₹102.11 (+16.3% YoY) with consolidated EBITDA of ₹236 Cr (30.7% margin), driven by an AI-first strategy and the Unbound Medicine acquisition.